The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats

Neil Patel, Richard T. Addo, Ruhi Ubale, Mohammed Nasir Uddin, Martin D'Souza, Lynetta Johnson Jobe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Increased NF-κB levels play a crucial role in the pathophysiology of heart failure and are known to cause ventricular remodeling. Antisense therapy can be used for blocking the expression of NF-κB and subsequently avoiding heart failure. However, as with most biotechnology products, molecular instability and overall cost are often the major issues and concerns limiting the advancement of most antisense drugs to the market. Therefore, a cost-efficient biodegradable sustained release particle drug delivery system to transport and target NF-kB antisense to its intended site of action would be ideal. Purpose: To evaluate the in vivo performance of a sustained release spray-dried albumin microsphere formulation for effective delivery and treatment of left ventricular remodeling with antisense to NF-κB. Methods: Albumin-based microspheres encapsulating antisense to NF-kB were prepared by spray drying and studied in a rat model to treat congestive heart failure. Results: The NF-κB activation and TNF-α release seen in treated animals were significantly lower than control animals. Ventricular remodeling was controlled in animals with antisense-treated AV fistulas as ΔV0-25 and ΔV0 were significantly lower compared to animals with untreated AV fistulas. Conclusion: This treatment was successful in curbing ventricular remodeling by suppressing NF-κB activation.

Original languageEnglish (US)
Pages (from-to)796-804
Number of pages9
JournalJournal of Drug Targeting
Volume22
Issue number9
DOIs
StatePublished - Nov 1 2014

Fingerprint

Ventricular Remodeling
Microspheres
Albumins
Heart Failure
NF-kappa B
Fistula
Costs and Cost Analysis
Drug Delivery Systems
Biotechnology
Therapeutics
Pharmaceutical Preparations

Keywords

  • Albumin microspheres
  • Antisense
  • Chronic volume overload
  • Drug delivery
  • Heart failure
  • Myocardial left ventricular remodeling
  • NF-kB
  • Spray-drying
  • Sustained release

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. / Patel, Neil; Addo, Richard T.; Ubale, Ruhi; Uddin, Mohammed Nasir; D'Souza, Martin; Jobe, Lynetta Johnson.

In: Journal of Drug Targeting, Vol. 22, No. 9, 01.11.2014, p. 796-804.

Research output: Contribution to journalArticle

Patel, Neil ; Addo, Richard T. ; Ubale, Ruhi ; Uddin, Mohammed Nasir ; D'Souza, Martin ; Jobe, Lynetta Johnson. / The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. In: Journal of Drug Targeting. 2014 ; Vol. 22, No. 9. pp. 796-804.
@article{b6d83f05b5304ddfa4625621f5bd95d9,
title = "The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats",
abstract = "Background: Increased NF-κB levels play a crucial role in the pathophysiology of heart failure and are known to cause ventricular remodeling. Antisense therapy can be used for blocking the expression of NF-κB and subsequently avoiding heart failure. However, as with most biotechnology products, molecular instability and overall cost are often the major issues and concerns limiting the advancement of most antisense drugs to the market. Therefore, a cost-efficient biodegradable sustained release particle drug delivery system to transport and target NF-kB antisense to its intended site of action would be ideal. Purpose: To evaluate the in vivo performance of a sustained release spray-dried albumin microsphere formulation for effective delivery and treatment of left ventricular remodeling with antisense to NF-κB. Methods: Albumin-based microspheres encapsulating antisense to NF-kB were prepared by spray drying and studied in a rat model to treat congestive heart failure. Results: The NF-κB activation and TNF-α release seen in treated animals were significantly lower than control animals. Ventricular remodeling was controlled in animals with antisense-treated AV fistulas as ΔV0-25 and ΔV0 were significantly lower compared to animals with untreated AV fistulas. Conclusion: This treatment was successful in curbing ventricular remodeling by suppressing NF-κB activation.",
keywords = "Albumin microspheres, Antisense, Chronic volume overload, Drug delivery, Heart failure, Myocardial left ventricular remodeling, NF-kB, Spray-drying, Sustained release",
author = "Neil Patel and Addo, {Richard T.} and Ruhi Ubale and Uddin, {Mohammed Nasir} and Martin D'Souza and Jobe, {Lynetta Johnson}",
year = "2014",
month = "11",
day = "1",
doi = "10.3109/1061186X.2014.921927",
language = "English (US)",
volume = "22",
pages = "796--804",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats

AU - Patel, Neil

AU - Addo, Richard T.

AU - Ubale, Ruhi

AU - Uddin, Mohammed Nasir

AU - D'Souza, Martin

AU - Jobe, Lynetta Johnson

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: Increased NF-κB levels play a crucial role in the pathophysiology of heart failure and are known to cause ventricular remodeling. Antisense therapy can be used for blocking the expression of NF-κB and subsequently avoiding heart failure. However, as with most biotechnology products, molecular instability and overall cost are often the major issues and concerns limiting the advancement of most antisense drugs to the market. Therefore, a cost-efficient biodegradable sustained release particle drug delivery system to transport and target NF-kB antisense to its intended site of action would be ideal. Purpose: To evaluate the in vivo performance of a sustained release spray-dried albumin microsphere formulation for effective delivery and treatment of left ventricular remodeling with antisense to NF-κB. Methods: Albumin-based microspheres encapsulating antisense to NF-kB were prepared by spray drying and studied in a rat model to treat congestive heart failure. Results: The NF-κB activation and TNF-α release seen in treated animals were significantly lower than control animals. Ventricular remodeling was controlled in animals with antisense-treated AV fistulas as ΔV0-25 and ΔV0 were significantly lower compared to animals with untreated AV fistulas. Conclusion: This treatment was successful in curbing ventricular remodeling by suppressing NF-κB activation.

AB - Background: Increased NF-κB levels play a crucial role in the pathophysiology of heart failure and are known to cause ventricular remodeling. Antisense therapy can be used for blocking the expression of NF-κB and subsequently avoiding heart failure. However, as with most biotechnology products, molecular instability and overall cost are often the major issues and concerns limiting the advancement of most antisense drugs to the market. Therefore, a cost-efficient biodegradable sustained release particle drug delivery system to transport and target NF-kB antisense to its intended site of action would be ideal. Purpose: To evaluate the in vivo performance of a sustained release spray-dried albumin microsphere formulation for effective delivery and treatment of left ventricular remodeling with antisense to NF-κB. Methods: Albumin-based microspheres encapsulating antisense to NF-kB were prepared by spray drying and studied in a rat model to treat congestive heart failure. Results: The NF-κB activation and TNF-α release seen in treated animals were significantly lower than control animals. Ventricular remodeling was controlled in animals with antisense-treated AV fistulas as ΔV0-25 and ΔV0 were significantly lower compared to animals with untreated AV fistulas. Conclusion: This treatment was successful in curbing ventricular remodeling by suppressing NF-κB activation.

KW - Albumin microspheres

KW - Antisense

KW - Chronic volume overload

KW - Drug delivery

KW - Heart failure

KW - Myocardial left ventricular remodeling

KW - NF-kB

KW - Spray-drying

KW - Sustained release

UR - http://www.scopus.com/inward/record.url?scp=84911498764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911498764&partnerID=8YFLogxK

U2 - 10.3109/1061186X.2014.921927

DO - 10.3109/1061186X.2014.921927

M3 - Article

C2 - 24892743

AN - SCOPUS:84911498764

VL - 22

SP - 796

EP - 804

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 9

ER -